Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Fish and Richardson
Medtronic
QuintilesIMS
Cerilliant
Express Scripts
Chinese Patent Office
Teva
McKinsey

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202739

« Back to Dashboard

NDA 202739 describes LEVONORGESTREL, which is a drug marketed by Wyeth Pharms Inc, Fdn Consumer, Glenmark Pharms Ltd, Lotus Pharm Co Ltd, Lupin Ltd, Mylan Labs Ltd, Novel Labs Inc, Oc Pharma, Perrigo R And D, Reckitt Benckiser, Watson Labs, Amneal Pharms, Glenmark Generics, Mayne Pharma, Barr, and Labs Leon Farma, and is included in thirty-nine NDAs. It is available from seven suppliers. Additional details are available on the LEVONORGESTREL profile page.

The generic ingredient in LEVONORGESTREL is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
Summary for 202739
Tradename:LEVONORGESTREL
Applicant:Mylan Labs Ltd
Ingredient:levonorgestrel
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 202739
Suppliers and Packaging for NDA: 202739
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEVONORGESTREL levonorgestrel TABLET;ORAL 202739 ANDA Afaxys Pharma, LLC 50102-111 N 50102-111-12

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength1.5MG
Approval Date:Oct 31, 2014TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cerilliant
Mallinckrodt
Healthtrust
AstraZeneca
Queensland Health
Argus Health
US Department of Justice
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.